Clinical Database and Biobank of Patients With Gynecologic Neoplasms

A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01267851

Enrollment

1600000

Registered

2010-12-29

Start date

2010-01-01

Completion date

2020-12-30

Last updated

2019-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Choriocarcinoma, Endometrial Cancer, Endometriosis, Ovarian Cancer, Uterine Myoma

Keywords

gynecologic disease

Brief summary

The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Detailed description

The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established. The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* patients with informed consent; * patients with gynecologic diseases; * patients with intact clinical and pathological information

Exclusion criteria

* not included in the inclusion criteria

Countries

China

Contacts

Primary ContactMa Ding, M.D.

dma@tjh.tjmu.edu.cn86-27-8362681

Outcome results